CCAAT/enhancer binding protein beta is up-regulated in giant cell tumor of bone and regulates RANKL expression

Journal of Cellular Biochemistry

Volumn 110, Issue 2, 2010, Pages 438-446

  Ng, Patrick Kwok Shing ^a   Tsui, Stephen Kwok Wing ^a   Lau, Carol Po Ying ^a   Wong, Chi Hang ^a   Wong, Winnie Hiu Ting ^a   Huang, Lin ^a   Kumta, Shekhar Madhukar ^a  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

C EBP ; Giant cell tumor of bone; Promoter analysis; RANKL; Stromal cells

Indexed keywords

CCAAT ENHANCER BINDING PROTEIN BETA; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; HEAT SHOCK TRANSCRIPTION FACTOR 2; NUCLEIC ACID BINDING PROTEIN; OSTEOCLAST DIFFERENTIATION FACTOR; TRANSCRIPTION FACTOR NRF2; TRANSCRIPTION FACTOR RUNX2; UNCLASSIFIED DRUG;

ANTIGEN EXPRESSION; ARTICLE; BONE TUMOR; CELL STIMULATION; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; DOSE RESPONSE; GENETIC TRANSFECTION; GIANT CELL TUMOR; HUMAN; HUMAN CELL; IN VIVO STUDY; MONOCYTE; MUTAGENESIS; PREDICTION; PRIORITY JOURNAL; PROMOTER REGION; REAL TIME POLYMERASE CHAIN REACTION; STROMA CELL; TUMOR CELL CULTURE; UPREGULATION;

BASE SEQUENCE; BONE NEOPLASMS; CCAAT-ENHANCER-BINDING PROTEIN-BETA; CHROMATIN IMMUNOPRECIPITATION; DNA PRIMERS; GENE EXPRESSION REGULATION; GIANT CELL TUMOR OF BONE; HUMANS; MOLECULAR SEQUENCE DATA; POLYMERASE CHAIN REACTION; PROMOTER REGIONS, GENETIC; RANK LIGAND; STROMAL CELLS; UP-REGULATION;

EID: 77952017371     PISSN: 07302312     EISSN: 10974644     Source Type: Journal    
DOI: 10.1002/jcb.22556     Document Type: Article

References (31)

1. Anderson DM, Maraskovsky E, Billingsley WL, Dougall WC, Tometsko ME, Roux ER, Teepe MC, DuBose RF, Cosman D, Galibert LA. 1997. A homologue of the TNF receptor and its ligand enhance T-cell growth and dendritic-cell function. Nature 390:175-179. (Pubitemid 27507987)
2. Bai XC, Lu D, Liu AL, Zhang ZM, Li XM, Zou ZP, Zeng WS, Cheng BL, Luo SQ. 2005. Reactive oxygen species stimulates receptor activator of NF-κB ligand expression in osteoblast. J Biol Chem 280:17497-17506. (Pubitemid 41389222)
3. Boyce BF, Xing L. 2008. Functions of RANKL/RANK/OPG in bone modeling and remodeling. Arch Biochem Biophys 473:139-146.
4. Chen G, Sircar K, Aprikian A, Potti A, Goltzman D, Rabbani SA. 2006. Expression of RANKL/RANK/OPG in primary and metastatic human prostate cancer as markers of disease stage and functional regulation. Cancer 107:289-298. (Pubitemid 44036558)
5. Cheng YY, Huang L, Lee KM, Xu JK, Zheng MH, Kumta SM. 2004. Bisphosphonates induce apoptosis of stromal tumor cells in giant cell tumor of bone. Calcif Tissue Int 75:71-77. (Pubitemid 38989221) (Pubitemid 38989221)
6. Fata JE, Kong YY, Li J, Sasaki T, Irie-Sasaki J, Moorehead RA, Elliott R, Scully S, Voura EB, Lacey DL, Boyle WJ, Khokha R, Penninger JM. 2000. The osteoclast differentiation factor osteoprotegerin-ligand is essential for mammary gland development. Cell 103:41-50.
7. Hofbauer LC, Heufelder AE. 2001. Role of receptor activator of nuclear factor-kappaB ligand and osteoprotegerin in bone cell biology. J Mol Med 76:243-253.
8. Hu Y, Sun M, Nadiminty N, Lou W, Pinder W, Gao AC. 2008. Transcriptional regulation of human RANK ligand gene expression by E2F1. Biochem Biophys Res Commun 370:440-444.
9. Huang L, Tang XY, Cheng YY, Lee KM, Kumta SM. 2004. Expression of preosteoblast markers and Cbfa-1 and osterix gene transcripts in stromal tumor cells of giant cell tumor of bone. Bone 34:393-401. (Pubitemid 38314904)
10. Huang L, Xu JK, Wood DJ, Zheng MH. 2000. Gene expression of osteoprotegerin ligand, osteoprotegerin, and receptor activator of NF-κB in giant cell tumor of bone. Am J Pathol 156:761-767.
11. 3 supports osteoclastogenesis via functional vitamin D response element of human RANKL gene promoter. J Cell Biochem 89:771-777.
12. Kong YY, Yoshida H, Sarosi I, Tan HL, Timms E, Capparelli C, Morony S, Oliveira DSA, Van G, Itie A, Khoo W, Wakeham A, Dunstan CR, Lacey DL, Mak TW, Boyle WJ, Penninger JM. 1999. OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph-mode organogenesis. Nature 397:315-323. (Pubitemid 29061638)
13. Liu J, Yang H, Liu W, Cao X, Feng X. 2005. Sp1 and Sp3 regulate the basal transcription of receptor activator of nuclear factor kappa B ligand gene in osteoblasts and bone marrow stromal cells. J Cell Biochem 96:716-727. (Pubitemid 41567543)
14. Lorenz C, Hofbauer MD, Michael Schoppet MD. 2004. Clinical implications of the osteoprotegerin/RANKL/RANK system for bone and vascular diseases. JAMA 292:490-495.
15. Mandrup S, Lane MD. 1997. Regulating adipogenesis. J Biol Chem 272:5367-5370.
16. Mori K, Berreur M, Blanchard F, Chevalier C, Guisle-Marsollier I, Masson M, Rédini F, Heymann D. 2007a. Receptor activator of nuclear factor-kappaB ligand (RANKL) directly modulates the gene expression profile of RANK-positive Saos-2 human osteosarcoma cells. Oncol Rep 18:1365-1371.
17. Mori K, Le Goff B, Berreur M, Riet A, Moreau A, Blanchard F, Chevalier C, Guisle-Marsollier I, Léger J, Guicheux J, Masson M, Gouin F, Rédini F, Heymann D. 2007b. Human osteosarcoma cells express functional receptor activator of nuclear factor-kappa B. J Pathol 211:555-562. (Pubitemid 46502432)
18. Murata A, Fujita T, Kawahara N, Tsuchiya H, Tomita K. 2005. Osteoblast lineage properties in giant cell tumors of bone. J Orthop Sci 10:581-588. (Pubitemid 41712706)
19. Niehof M, Streetz K, Rakemann T, Bischoff SC, Manns MP, Horn F, Trautwein C. 2001. Interleukin-6-induced tethering of STAT3 to the LAP/C/EBPβ promoter suggests a new mechanism of transcriptional regulation by STAT3. J Biol Chem 276:9016-9027. (Pubitemid 37385479)
20. O'Brien CA, Gubrij I, Lin SC, Saylors RL, Manolagas SC. 1999. STAT3 activation in stromal osteoblastic cells is required for induction of the receptor activator of NF-kappa B ligand and stimulation of osteoclastogenesis by gp130-utilizing cytokines or interleukin-1 but not 1,25-dihydroxyvitamin D-3 or parathyroid hormone. J Biol Chem 274:19301-19308. (Pubitemid 129519359)
21. Ohsaki Y, Takahashi S, Scarez T, Demulder A, Nishibara T, Williams R, Roodman GD. 1992. Evidence for an autocine/paracrine role for interleukin-6 in bone resorption by giant cells from giant cell tumors of bone. Endocrinology 131:2229-2234.
22. Osada S, Yamaoto H, Nishihara T, Imagawa W. 1996. DNA binding specificity of the CCAAT/enhancer-binding protein transcription factor family. J Biol Chem 271:3891-3896. (Pubitemid 26065711)
23. Ramji DP, Foka P. 2002. CCAAT/enhancer-binding proteins: Structure, function and regulation. Biochem J 365:561-575. (Pubitemid 34864439)
24. Roccisana JL, Kawanabe N, Kajiya H, Koide M, Roodman GD, Reddy SV. 2004. Functional role for heat shock factors in the transcriptional regulation of human RANK ligand gene expression in stromal/osteoblast cells. J Biol Chem 279:10500-10507. (Pubitemid 38372660)
25. Suda T, Takahashi N, Udagawa N, Jimi E, Gillespie MT, Martin TJ. 1999. Modulation of oestoclast differentiation and function by the new members of the tumor necrosis factor receptor and ligand families. Endocr Rev 20:345-357. (Pubitemid 30649812) (Pubitemid 30649812)
26. Sun SG, Lau YS, Itonaga I, Sabokbar A, Athanasou NA. 2006. Bone stromal cells in pagetic bone and Paget's sarcoma express RANKL and support human osteoclast formation. J Pathol 209:114-120.
27. Udagawa N, Takahashi N, Katagiri T, Tamura T, Wada S, Findlay DM, Martin TJ, Hirota H, Taga T, Kishimoto T, Suda T. 1995. Interleukin (IL)-6 induction of osteoclast differentiation depends on IL-6 receptors expressed on osteoblastic cells but not on osteoclast progenitors. J Exp Med 182:1461-1468.
28. Van Poznak C, Cross SS, Saggese M, Hudis C, Panageas KS, Norton L, Coleman RE, Holen I. 2006. Expression of osteoprotegerin (OPG), TNF related apoptosis inducing ligand (TRAIL), and receptor activator of nuclear factor kappaB ligand (RANKL) in human breast tumors. J Clin Pathol 59:56-63. (Pubitemid 43076239)
29. Wulling M, Kaiser E. 2003. The origin of the neoplastic stromal cell in giant cell tumor of bone. Hum Pathol 34:983-993. (Pubitemid 37315249)
30. Yip MH, Leung PC, Kumta SM. 1996. Giant cell tumor of bone. Clin Orthop 323:60-64.
31. Zheng MH, Robbins P, Xu J, Huang L, Wood DJ, Papadimitriou JM. 2001. The histogenesis of giant cell tumor of bone: A model of interaction between neoplastic cells and osteoclasts. Histol Histopathol 16:297-307. (Pubitemid 32094046)